carbidopa has been researched along with Anoxia, Brain in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bowers, MB; Howieson, J; Rosenbaum, D; Van Woert, MH | 1 |
| Chadwick, D; Hallett, M; Harris, R; Jenner, P; Marsden, CD; Reynolds, EH | 1 |
2 other study(ies) available for carbidopa and Anoxia, Brain
| Article | Year |
|---|---|
Long-term therapy of myoclonus and other neurologic disorders with L-5-hydroxytryptophan and carbidopa.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Brain; Carbidopa; Drug Therapy, Combination; Epilepsies, Myoclonic; Female; Humans; Hydrazines; Hypoxia, Brain; Long-Term Care; Male; Middle Aged; Myoclonus; Serotonin; Tryptophan | 1977 |
Clinical, biochemical, and physiological features distinguishing myoclonus responsive to 5-hydroxytryptophan, tryptophan with a monoamine oxidase inhibitor, and clonazepam.
Topics: 5-Hydroxytryptophan; Adolescent; Adult; Aged; Benzodiazepinones; Carbidopa; Child, Preschool; Clonazepam; Dose-Response Relationship, Drug; Drug Therapy, Combination; Electroencephalography; Electromyography; Epilepsies, Myoclonic; Epilepsy, Post-Traumatic; Female; Homovanillic Acid; Humans; Hydrazines; Hydroxyindoleacetic Acid; Hypoxia, Brain; Isocarboxazid; Male; Methysergide; Middle Aged; Myoclonus; Premedication; Tryptophan | 1977 |